Contact Us
Oncology

Oncology

Oncology Portfolio

Oncology

Several types of oncologic API and intermediates are under development. To have the latest status please contact with us. 


Idelalisib

Pazopanib

Palbociclib

Ponatinib HCl

Rucaparib

Provide Comprehensive Solution For
Global Patients
Fill out the form to leave inquiries. We would get back to you as soon as possible.